ANTIBODY-DRUG CONJUGATE TARGETING NECTIN-4 AND PREPARATION METHOD THEREFOR AND USE THEREOF

An antibody-drug conjugate targeting a poliovirus receptor-like molecule 4 (Nectin-4). The antibody-drug conjugate can be used for preparing a drug for treating Nectin-4-related diseases. The antibody-drug conjugate has strong targeting properties to Nectin-4 and a strong endocytosis effect via the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ZHOU, WEI, TAN, XIAODING, LIU, DATAO
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ZHOU, WEI
TAN, XIAODING
LIU, DATAO
description An antibody-drug conjugate targeting a poliovirus receptor-like molecule 4 (Nectin-4). The antibody-drug conjugate can be used for preparing a drug for treating Nectin-4-related diseases. The antibody-drug conjugate has strong targeting properties to Nectin-4 and a strong endocytosis effect via the target, and has an excellent tumor-killing effect. L'invention concerne un conjugué anticorps-médicament ciblant une molécule 4 de type récepteur de poliovirus (nectine-4). Le conjugué anticorps-médicament peut être utilisé pour préparer un médicament pour le traitement de maladies liées à la nectine-4. Le conjugué anticorps-médicament possède de fortes propriétés de ciblage vis-à-vis de la nectine-4 et un puissant effet d'endocytose par l'intermédiaire de la cible, et présente un excellent effet d'élimination des tumeurs.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3217112A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3217112A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3217112A13</originalsourceid><addsrcrecordid>eNqNijsKAjEUANNYiHqHd4EU2RWsn8nLRzBZ4kuxNssisRJdWO-Poh7AamBmluKMkcM-mV6aXBzoFA_FIRMwZkccooNI-k25BYwGukwdZuSQIhyJfTLAnjLZlD-9nOgrkl2LxXW8zXXz40qAJdZe1ukx1HkaL_Ven4PGtlE7pRpU7R_LC-QNMQ4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTIBODY-DRUG CONJUGATE TARGETING NECTIN-4 AND PREPARATION METHOD THEREFOR AND USE THEREOF</title><source>esp@cenet</source><creator>ZHOU, WEI ; TAN, XIAODING ; LIU, DATAO</creator><creatorcontrib>ZHOU, WEI ; TAN, XIAODING ; LIU, DATAO</creatorcontrib><description>An antibody-drug conjugate targeting a poliovirus receptor-like molecule 4 (Nectin-4). The antibody-drug conjugate can be used for preparing a drug for treating Nectin-4-related diseases. The antibody-drug conjugate has strong targeting properties to Nectin-4 and a strong endocytosis effect via the target, and has an excellent tumor-killing effect. L'invention concerne un conjugué anticorps-médicament ciblant une molécule 4 de type récepteur de poliovirus (nectine-4). Le conjugué anticorps-médicament peut être utilisé pour préparer un médicament pour le traitement de maladies liées à la nectine-4. Le conjugué anticorps-médicament possède de fortes propriétés de ciblage vis-à-vis de la nectine-4 et un puissant effet d'endocytose par l'intermédiaire de la cible, et présente un excellent effet d'élimination des tumeurs.</description><language>eng ; fre</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221103&amp;DB=EPODOC&amp;CC=CA&amp;NR=3217112A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221103&amp;DB=EPODOC&amp;CC=CA&amp;NR=3217112A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHOU, WEI</creatorcontrib><creatorcontrib>TAN, XIAODING</creatorcontrib><creatorcontrib>LIU, DATAO</creatorcontrib><title>ANTIBODY-DRUG CONJUGATE TARGETING NECTIN-4 AND PREPARATION METHOD THEREFOR AND USE THEREOF</title><description>An antibody-drug conjugate targeting a poliovirus receptor-like molecule 4 (Nectin-4). The antibody-drug conjugate can be used for preparing a drug for treating Nectin-4-related diseases. The antibody-drug conjugate has strong targeting properties to Nectin-4 and a strong endocytosis effect via the target, and has an excellent tumor-killing effect. L'invention concerne un conjugué anticorps-médicament ciblant une molécule 4 de type récepteur de poliovirus (nectine-4). Le conjugué anticorps-médicament peut être utilisé pour préparer un médicament pour le traitement de maladies liées à la nectine-4. Le conjugué anticorps-médicament possède de fortes propriétés de ciblage vis-à-vis de la nectine-4 et un puissant effet d'endocytose par l'intermédiaire de la cible, et présente un excellent effet d'élimination des tumeurs.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNijsKAjEUANNYiHqHd4EU2RWsn8nLRzBZ4kuxNssisRJdWO-Poh7AamBmluKMkcM-mV6aXBzoFA_FIRMwZkccooNI-k25BYwGukwdZuSQIhyJfTLAnjLZlD-9nOgrkl2LxXW8zXXz40qAJdZe1ukx1HkaL_Ven4PGtlE7pRpU7R_LC-QNMQ4</recordid><startdate>20221103</startdate><enddate>20221103</enddate><creator>ZHOU, WEI</creator><creator>TAN, XIAODING</creator><creator>LIU, DATAO</creator><scope>EVB</scope></search><sort><creationdate>20221103</creationdate><title>ANTIBODY-DRUG CONJUGATE TARGETING NECTIN-4 AND PREPARATION METHOD THEREFOR AND USE THEREOF</title><author>ZHOU, WEI ; TAN, XIAODING ; LIU, DATAO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3217112A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHOU, WEI</creatorcontrib><creatorcontrib>TAN, XIAODING</creatorcontrib><creatorcontrib>LIU, DATAO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHOU, WEI</au><au>TAN, XIAODING</au><au>LIU, DATAO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTIBODY-DRUG CONJUGATE TARGETING NECTIN-4 AND PREPARATION METHOD THEREFOR AND USE THEREOF</title><date>2022-11-03</date><risdate>2022</risdate><abstract>An antibody-drug conjugate targeting a poliovirus receptor-like molecule 4 (Nectin-4). The antibody-drug conjugate can be used for preparing a drug for treating Nectin-4-related diseases. The antibody-drug conjugate has strong targeting properties to Nectin-4 and a strong endocytosis effect via the target, and has an excellent tumor-killing effect. L'invention concerne un conjugué anticorps-médicament ciblant une molécule 4 de type récepteur de poliovirus (nectine-4). Le conjugué anticorps-médicament peut être utilisé pour préparer un médicament pour le traitement de maladies liées à la nectine-4. Le conjugué anticorps-médicament possède de fortes propriétés de ciblage vis-à-vis de la nectine-4 et un puissant effet d'endocytose par l'intermédiaire de la cible, et présente un excellent effet d'élimination des tumeurs.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA3217112A1
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title ANTIBODY-DRUG CONJUGATE TARGETING NECTIN-4 AND PREPARATION METHOD THEREFOR AND USE THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T12%3A41%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHOU,%20WEI&rft.date=2022-11-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3217112A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true